alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health 

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. 

The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         Training Grant and Career Development Review Committee.                     

*Date:*                         September 13-14, 2007.                     

*Time:*                         8 a.m. to 5 p.m.                     

*Agenda:*                         To review and evaluate grant applications.                     

*Place:*                         Renaissance Mayflower Hotel, 1127 Connecticut Avenue, NW., Washington, DC 20036.                     

*Contact Person:*                         Raul A. Saavedra, PhD, Scientific Review Administrator, Scientific Review Branch, Division of Extramural Research, NINDS/NIH/DHHS, NSC; 6001 Executive Blvd., Ste. 3208, Bethesda, MD 20892-9529, 301-496-9223,                         *saavedrr@ninds.nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, Clinical Research Related to Neurological Disorders; 93.854, Biological Basis Research in the Neurosciences, National Institutes of Health, HHS)

Dated: August 9, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory Committee Policy. 

[FR Doc. 07-4014 Filed 8-15-07; 8:45 am] 

BILLING CODE 4140-01-M
Editorial Note on Part 190
Editorial Note: Nomenclature changes to part 190 appear at 78 FR 58908, Sept. 25, 2013.

§ 190.315 Contents of notices of proposed rulemaking. ( a ) Each notice of proposed rulemaking is published in the Federal Register, unless all persons subject to it are named and are personally served with a copy of it.
( b ) Each notice, whether published in the Federal Register or personally served, includes: ( 1 ) A statement of the time, place, and nature of the proposed rulemaking proceeding;
( 2 ) A reference to the authority under which it is issued;
( 3 ) A description of the subjects and issues involved or the substance and terms of the proposed regulation;
( 4 ) A statement of the time within which written comments must be submitted; and
( 5 ) A statement of how and to what extent interested persons may participate in the proceeding.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>

This schedule contains summary financial information extracted from the 
financial statements in the Quarterly Report on Form 10-Q of VLSI Technology, 
Inc. for the six months ended June 27, 1997 and is qualified in its entirety 
by reference to such financial statements.

</LEGEND>
<CIK>                                        0000704386
<NAME>                             VLSI TECHNOLOGY, INC.
<MULTIPLIER>                                      1,000
<CURRENCY>                                          USD
       
<S>                                         <C>
<PERIOD-TYPE>                                     6-MOS
<FISCAL-YEAR-END>                           DEC-26-1997
<PERIOD-START>                              DEC-28-1996
<PERIOD-END>                                JUN-27-1997
<EXCHANGE-RATE>                                       1
<CASH>                                          131,668
<SECURITIES>                                     94,533
<RECEIVABLES>                                   114,834
<ALLOWANCES>                                      2,100
<INVENTORY>                                      53,983
<CURRENT-ASSETS>                                457,208
<PP&E>                                          812,913
<DEPRECIATION>                                 (393,939)
<TOTAL-ASSETS>                                  892,411
<CURRENT-LIABILITIES>                           203,670
<BONDS>                                         205,493
<COMMON>                                            472
<PREFERRED-MANDATORY>                                 0
<PREFERRED>                                           0
<OTHER-SE>                                      482,776
<TOTAL-LIABILITY-AND-EQUITY>                    892,411
<SALES>                                         360,156
<TOTAL-REVENUES>                                360,156
<CGS>                                           201,700
<TOTAL-COSTS>                                   201,700
<OTHER-EXPENSES>                                124,498
<LOSS-PROVISION>                                   (196)
<INTEREST-EXPENSE>                                5,851
<INCOME-PRETAX>                                  31,339
<INCOME-TAX>                                     10,020
<INCOME-CONTINUING>                              21,319
<DISCONTINUED>                                        0
<EXTRAORDINARY>                                       0
<CHANGES>                                             0
<NET-INCOME>                                     21,319
<EPS-PRIMARY>                                      0.44
<EPS-DILUTED>                                      0.44
        



			
			
		












</TABLE>
###### Editorial Note on Part 195

#### Editorial Note:

Nomenclature changes to part 195 appear at 71 FR 33409, June 9, 2006.

#### § 195.434 Signs.

Each operator must maintain signs visible to the public around each pumping station and breakout tank area. Each sign must contain the name of the operator and a telephone number (including area code) where the operator can be reached at all times.

[Amdt. 195-78, 68 FR 53528, Sept. 11, 2003]
EXHIBIT 21.0

                           Subsidiaries of Registrant

                                 Subsidiaries of

                            OREGON STEEL MILLS, INC.

              Canadian National Steel Corporation - Alberta, Canada
           Camrose Pipe Company (a partnership) - Alberta, Canada (3)
                      Camrose Pipe Corporation - Delaware -
                         dba Columbia Structural Tubing
                          New CF&I, Inc. - Delaware (1)
                    Oregon Steel de Guayana, Inc. - Delaware
                     OSM Classification (TM), Inc. - Oregon
                  CF&I Steel, L.P. (a partnership) - Delaware -
                       dba Rocky Mountain Steel Mills (2)
                  Colorado & Wyoming Railway Company - Delaware
                        OSM Distribution, Inc. - Delaware
                 Oregon Steel Mills Processing, Inc. - Delaware
              Oregon Feralloy Partners (a partnership) - Oregon (4)
                     LSI Plate (a partnership) - Oregon (5)

(1)   The Company owns 87% of New CF&I, Inc.

(2)   New CF&I, the general partner of CF&I, owns 95.2% and 100% of the equity
      interest in CF&I and Colorado & Wyoming Railway Company, respectively. In
      addition, the Company directly owns 4.3% of the equity interest in CF&I,
      Steel L.P.

(3)   The Company owns 60% of Camrose Pipe Company.

(4)   The Company owns 60% of Oregon Feralloy Partners.

(5)   The Company Owns 50% of LSI Plate.

The Company owns 100% of all remaining subsidiaries listed.
-----Original Message----- 

Sent: Monday, April 26, 2010 5:16 AM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 26, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

J. Leventer
-----Original Message----- 

From: pjh372@comcast.net [mailto:pjh372@comcast.net] 

Sent: Saturday, April 24, 2010 9:09 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 24, 2010 

I am writing to support the interim final rule under the Paul Wellstone and 

Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (RIN 

1210-AB30). 

I support the strong rule that would forbid insurance companies from charging 

higher copayments, deductibles, and other out-of-pocket expenses for mental 

health treatment than they would for other physical health care. Thank you 

for ensuring that mental health care and physical health care coverage are 

included in a single deductible. 

Sincerely, 

Penny Harmon 

3712 Hillbrook Drive 

Nashville, TN 37211
CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350,


AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the accompanying Annual Report on Form 10Q of Viropro Inc. (the “Company”) for the period ended June 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), and pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, Rajiv Datar, as Chief Executive Officer of the Company, and Claude Gingras, as Chief Financial Officer of the Company, hereby certify that:




(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and





(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.








/s/   Rajiv Datar


Rajiv Datar


Chief Executive Officer








/s/   Claude Gingras


Claude Gingras


Chief Financial Officer
-----Original Message----- 

From: moose7276@yahoo.com [mailto:moose7276@yahoo.com] 

Sent: Sunday, April 25, 2010 4:45 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 25, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

Jeff Watters 

P.O.Box 395 

Brice, OH 43109
From: dmcferon@hotmail.com [mailto:dmcferon@hotmail.com] 

Sent: Sunday, April 25, 2010 1:24 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 25, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

Diane Nash-McFeron 

2923 NE 199th Street 

Shoreline, WA 98155
Editorial Note on Part 195
Editorial Note: Nomenclature changes to part 195 appear at 71 FR 33409, June 9, 2006.

§ 195.444 Leak detection. ( a ) *Scope.* Except for offshore gathering and regulated rural gathering pipelines, this section applies to all hazardous liquid pipelines transporting liquid in single phase (without gas in the liquid).
( b ) *General.* A pipeline must have an effective system for detecting leaks in accordance with §§ 195.134 or 195.452, as appropriate. An operator must evaluate the capability of its leak detection system to protect the public, property, and the environment and modify it as necessary to do so. At a minimum, an operator's evaluation must consider the following factors—length and size of the pipeline, type of product carried, the swiftness of leak detection, location of nearest response personnel, and leak history.
( c ) *CPM leak detection systems.* Each computational pipeline monitoring (CPM) leak detection system installed on a hazardous liquid pipeline must comply with API RP 1130 (incorporated by reference, see § 195.3) in operating, maintaining, testing, record keeping, and dispatcher training of the system.
[Amdt. 195-102, 84 FR 52296, Oct. 1, 2019]
**Exhibit 32.2**

 

CERTIFICATION PURSUANT TO18 U.S.C. SECTION 1350AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the quarterly report ofPaulson Capital Corp., Inc. (the “Company”) on Form 10-Q for theperiod ending September 30, 2005 as filed with the Securities and ExchangeCommission on the date hereof (the “Report”), I, Carol A. Rice, Chief FinancialOfficer of the Company, certify pursuant to 18 U.S.C. Section 1350, asadopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that,to the best of my knowledge:

 

(1)                                  The Report fullycomplies with the requirements of Section 13(a) or 15(d) of theSecurities Exchange Act of 1934; and

 

(2)                                  The informationcontained in the Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 
| /s/ Carol A. Rice       |   |
|-------------------------|--------|
| Carol A. Rice           |
| Chief Financial Officer |
| November 11, 2005  |

 

----
-----Original Message----- 

From: nicoledupre@rcn.com [mailto:nicoledupre@rcn.com] 

Sent: Sunday, April 25, 2010 7:53 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 25, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. I know from family experience the toll that mental health 

issues can take, and they are as real and devastating as physical 

health issues. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

Nicole Dupre 

22 Rose Street 

Somerville, MA 02143
**EXHIBIT31.2**

**CERTIFICATION OF CHIEF FINANCIALOFFICER**

**PURSUANT TO RULE 13a-14(a) ORRULE 15d-14(a)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

I, Karen L.Johannes, certify that:

1.               I have reviewedthis quarterly report on Form 10-Q of Paulson Capital Corp.;

2.               Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3.               Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4.               The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)and 15d-15(e)) for the registrant and have:

(a) Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designedunder our supervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made known to us byothers within those entities, particularly during the period in which thisreport is being prepared;

(b)  [Reserved.]

(c)  Evaluated the effectiveness of the registrant’sdisclosure controls and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures, as of theend of the period covered by this report based on such evaluation; and

(d)  Disclosed in this report any change in theregistrant’s internal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarterin the case of an annual report) that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control over financialreporting; and

5.               The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (orpersons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operationof internal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

(b)Any fraud, whether or not material, that involves management or other employeeswho have a significant role in the registrant’s internal control over financialreporting.

Date: August 10,2007
| /s/ Karen L. Johannes    |   |
|--------------------------|--------|
| Karen L.  Johannes       |
| Chief Financial  Officer |
| Paulson Capital  Corp.   |

 

----
```

[Journal of the House of Representatives, 1995]
[Wednesday, July 26, 1995 (102), Para 102.38 Leave of Absence]
[Page 1204]
[From the U.S. Government Publishing Office, www.gpo.gov]

para.102.38  leave of absence

  By unanimous consent, leave of absence was granted to Mrs. CHENOWETH, 
for today.
  And then,
```
-----Original Message----- 

From: saurbanc@gmail.com [mailto:saurbanc@gmail.com] 

Sent: Saturday, April 24, 2010 6:08 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 24, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

steven urbanc 

1273 cedar 

Port Townsend, WA 98368
[Federal Register Volume 72, Number 155 (Monday, August 13, 2007)]
[Notices]
[Pages 45276-45277]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 07-3937]


=======================================================================
-----------------------------------------------------------------------

NUCLEAR WASTE TECHNICAL REVIEW BOARD


Notice of Meeting

    Board meeting: September 19, 2007--Las Vegas, Nevada; The U.S. 
Nuclear Waste Technical Review Board will meet to discuss U.S. 
Department of Energy activities related to the possible development of 
a repository for spent nuclear fuel and high-level radioactive waste at 
Yucca Mountain in Nevada.
    Pursuant to its authority under section 5051 of Public Law 100-203, 
Nuclear Waste Policy Amendments Act of 1987, the U.S. Nuclear Waste 
Technical Review Board will meet in Las Vegas, Nevada on Wednesday, 
September 19, 2007. The Board was created in the Nuclear Waste Policy 
Amendments Act of 1987 and charged with performing an independent 
review of the technical and scientific validity of U.S. Department of 
Energy (DOE) activities related to implementing the Nuclear Waste 
Policy Act. Such activities include characterizing the proposed 
repository site for disposing of spent nuclear fuel and high-level 
radioactive waste at Yucca Mountain in Nevada and packaging and 
transporting the waste.
    The focus of the meeting, which will be open to the public, will be 
repository surface-facility designs and operations; other technical 
issues also may be discussed. A final meeting agenda will be available 
on the Board's Web site (www.nwtrb.gov) or by telephone request 
approximately one week before the meeting date.
    The meeting will be held at the Atrium Suites Hotel; 4255 S. 
Paradise Road; Las Vegas, Nevada 89109; (tel) 702-369-4400; (res) 866-
404-5286; (fax) 702-369-4330.
    The meeting will begin at 8 a.m. Time will be set aside at the end 
of the day for public comments. Those wanting to speak are encouraged 
to sign the ``Public Comment Register'' at the check-in table. A time 
limit may have to be set on individual remarks, but written comments of 
any length may be submitted for the record.
    Transcripts of the meeting will be available on the Board's Web 
site, by e-mail, on computer disk, and on a

[[Page 45277]]

library-loan basis in paper format from Davonya Barnes of the Board's 
staff no later than October 15, 2007.
    A block of rooms has been reserved for meeting participants at the 
Atrium Suites. When making a reservation, please state that you are 
attending the NWTRB meeting. Reservations should be made by August 27, 
2007, to ensure receiving the meeting rate.
    For more information, contact Karyn Severson, NWTRB External 
Affairs; 2300 Clarendon Boulevard, Suite 1300; Arlington, VA 22201-
3367; (tel) 703-235-4473; (fax) 703-235-4495.

    Dated: August 7, 2007.
William D. Barnard,
Executive Director, Nuclear Waste Technical Review Board.
[FR Doc. 07-3937 Filed 8-10-07; 8:45 am]
BILLING CODE 6820-NM-M
-----Original Message----- 

From: joel.k.cohen@comcast.net [mailto:joel.k.cohen@comcast.net] 

Sent: Sunday, April 25, 2010 9:55 PM 

To: EBSA, E-OHPSCA - EBSA 

Subject: Comment in support of RIN 1210-AB30 

April 25, 2010 

I am writing to support the interim final rule under the Paul Wellstone 

and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 

(RIN 1210-AB30). 

I support the strong rule that would forbid insurance companies from 

charging higher copayments, deductibles, and other out-of-pocket 

expenses for mental health treatment than they would for other physical 

health care. Thank you for ensuring that mental health care and 

physical health care coverage are included in a single deductible. 

Sincerely, 

Joel Cohen 

74 Robbins Dr 

Carlisle, MA 01741